Publication Information

{'id': 'https://openalex.org/W59500062', 'doi': 'https://doi.org/10.1080/00034983.1992.11812712', 'title': 'Mefloquine-sulphadoxine-pyrimethamine (Fansimef®, Roche) in the prophylaxis of<i>Plasmodium falciparum</i>malaria: a double-blind, comparative, placebo-controlled study', 'display_name': 'Mefloquine-sulphadoxine-pyrimethamine (Fansimef®, Roche) in the prophylaxis of<i>Plasmodium falciparum</i>malaria: a double-blind, comparative, placebo-controlled study', 'publication_year': 1992, 'publication_date': '1992-01-01', 'ids': {'openalex': 'https://openalex.org/W59500062', 'doi': 'https://doi.org/10.1080/00034983.1992.11812712', 'mag': '59500062', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/1304698'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1080/00034983.1992.11812712', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S135866459', 'display_name': 'Annals of Tropical Medicine and Parasitology', 'issn_l': '0003-4983', 'issn': ['0003-4983', '1364-8594'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320442', 'host_organization_name': 'Maney Publishing', 'host_organization_lineage': ['https://openalex.org/P4310320442'], 'host_organization_lineage_names': ['Maney Publishing'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5111594876', 'display_name': 'L.A. Salako', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I181631907', 'display_name': 'University of Ibadan', 'ror': 'https://ror.org/03wx2rr30', 'country_code': 'NG', 'type': 'education', 'lineage': ['https://openalex.org/I181631907']}], 'countries': ['NG'], 'is_corresponding': False, 'raw_author_name': 'L. A. Salako', 'raw_affiliation_strings': ['Department of Pharmacology and Therapeutics, University of Ibadan, Nigeria'], 'affiliations': [{'raw_affiliation_string': 'Department of Pharmacology and Therapeutics, University of Ibadan, Nigeria', 'institution_ids': ['https://openalex.org/I181631907']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5001501803', 'display_name': 'Risquat A. Adio', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I181631907', 'display_name': 'University of Ibadan', 'ror': 'https://ror.org/03wx2rr30', 'country_code': 'NG', 'type': 'education', 'lineage': ['https://openalex.org/I181631907']}], 'countries': ['NG'], 'is_corresponding': False, 'raw_author_name': 'R. A. Adio', 'raw_affiliation_strings': ['Department of Pharmacology and Therapeutics, University of Ibadan, Nigeria'], 'affiliations': [{'raw_affiliation_string': 'Department of Pharmacology and Therapeutics, University of Ibadan, Nigeria', 'institution_ids': ['https://openalex.org/I181631907']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5037837820', 'display_name': 'O. Walker', 'orcid': 'https://orcid.org/0000-0003-3544-419X'}, 'institutions': [{'id': 'https://openalex.org/I181631907', 'display_name': 'University of Ibadan', 'ror': 'https://ror.org/03wx2rr30', 'country_code': 'NG', 'type': 'education', 'lineage': ['https://openalex.org/I181631907']}], 'countries': ['NG'], 'is_corresponding': False, 'raw_author_name': 'O. Walker', 'raw_affiliation_strings': ['Department of Pharmacology and Therapeutics, University of Ibadan, Nigeria'], 'affiliations': [{'raw_affiliation_string': 'Department of Pharmacology and Therapeutics, University of Ibadan, Nigeria', 'institution_ids': ['https://openalex.org/I181631907']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5108091127', 'display_name': 'A. Sowunmi', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I181631907', 'display_name': 'University of Ibadan', 'ror': 'https://ror.org/03wx2rr30', 'country_code': 'NG', 'type': 'education', 'lineage': ['https://openalex.org/I181631907']}], 'countries': ['NG'], 'is_corresponding': False, 'raw_author_name': 'A. Sowunmi', 'raw_affiliation_strings': ['Department of Pharmacology and Therapeutics, University of Ibadan, Nigeria'], 'affiliations': [{'raw_affiliation_string': 'Department of Pharmacology and Therapeutics, University of Ibadan, Nigeria', 'institution_ids': ['https://openalex.org/I181631907']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5033441919', 'display_name': 'D Stürchler', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'D. Stürchler', 'raw_affiliation_strings': ['F. Hoffman-La Roche Pharma Clinical Research Department, CH-4200 Basel, Switzerland'], 'affiliations': [{'raw_affiliation_string': 'F. Hoffman-La Roche Pharma Clinical Research Department, CH-4200 Basel, Switzerland', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109846001', 'display_name': 'M L Mittelholzer', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'M.-L. Mittelholzer', 'raw_affiliation_strings': ['F. Hoffman-La Roche Pharma Clinical Research Department, CH-4200 Basel, Switzerland'], 'affiliations': [{'raw_affiliation_string': 'F. Hoffman-La Roche Pharma Clinical Research Department, CH-4200 Basel, Switzerland', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5017041761', 'display_name': 'R Reber-Liske', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'R. Reber-Liske', 'raw_affiliation_strings': ['F. Hoffman-La Roche Pharma Clinical Research Department, CH-4200 Basel, Switzerland'], 'affiliations': [{'raw_affiliation_string': 'F. Hoffman-La Roche Pharma Clinical Research Department, CH-4200 Basel, Switzerland', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5070427004', 'display_name': 'U. Dickschat', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'U. Dickschat', 'raw_affiliation_strings': ['F. Hoffman-La Roche Pharma Clinical Research Department, CH-4200 Basel, Switzerland'], 'affiliations': [{'raw_affiliation_string': 'F. Hoffman-La Roche Pharma Clinical Research Department, CH-4200 Basel, Switzerland', 'institution_ids': ['https://openalex.org/I118019719']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.295, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 12, 'citation_normalized_percentile': {'value': 0.690638, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 79, 'max': 80}, 'biblio': {'volume': '86', 'issue': '6', 'first_page': '575', 'last_page': '581'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10526', 'display_name': 'HIV/AIDS drug development and treatment', 'score': 0.969, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10526', 'display_name': 'HIV/AIDS drug development and treatment', 'score': 0.969, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10649', 'display_name': 'Multiple Myeloma Research and Treatments', 'score': 0.9624, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11235', 'display_name': 'Statistical Methods in Clinical Trials', 'score': 0.9457, 'subfield': {'id': 'https://openalex.org/subfields/2613', 'display_name': 'Statistics and Probability'}, 'field': {'id': 'https://openalex.org/fields/26', 'display_name': 'Mathematics'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/artesunate', 'display_name': 'Artesunate', 'score': 0.57505256}, {'id': 'https://openalex.org/keywords/sulfadoxine', 'display_name': 'Sulfadoxine', 'score': 0.5137328}], 'concepts': [{'id': 'https://openalex.org/C2777199930', 'wikidata': 'https://www.wikidata.org/wiki/Q736270', 'display_name': 'Mefloquine', 'level': 4, 'score': 0.8365904}, {'id': 'https://openalex.org/C2778048844', 'wikidata': 'https://www.wikidata.org/wiki/Q12156', 'display_name': 'Malaria', 'level': 2, 'score': 0.80603707}, {'id': 'https://openalex.org/C2778371730', 'wikidata': 'https://www.wikidata.org/wiki/Q311383', 'display_name': 'Plasmodium falciparum', 'level': 3, 'score': 0.7778786}, {'id': 'https://openalex.org/C2777035104', 'wikidata': 'https://www.wikidata.org/wiki/Q421072', 'display_name': 'Pyrimethamine', 'level': 4, 'score': 0.7263117}, {'id': 'https://openalex.org/C3019824283', 'wikidata': 'https://www.wikidata.org/wiki/Q353172', 'display_name': 'Protozoal disease', 'level': 3, 'score': 0.5801525}, {'id': 'https://openalex.org/C2778059366', 'wikidata': 'https://www.wikidata.org/wiki/Q707939', 'display_name': 'Artesunate', 'level': 4, 'score': 0.57505256}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.5285379}, {'id': 'https://openalex.org/C159047783', 'wikidata': 'https://www.wikidata.org/wiki/Q7215', 'display_name': 'Virology', 'level': 1, 'score': 0.5268611}, {'id': 'https://openalex.org/C2778301690', 'wikidata': 'https://www.wikidata.org/wiki/Q411557', 'display_name': 'Sulfadoxine', 'level': 5, 'score': 0.5137328}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.40029255}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.32244974}], 'mesh': [{'descriptor_ui': 'D000962', 'descriptor_name': 'Antimalarials', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D016778', 'descriptor_name': 'Malaria, Falciparum', 'qualifier_ui': 'Q000517', 'qualifier_name': 'prevention & control', 'is_major_topic': True}, {'descriptor_ui': 'D015767', 'descriptor_name': 'Mefloquine', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': True}, {'descriptor_ui': 'D011739', 'descriptor_name': 'Pyrimethamine', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D013413', 'descriptor_name': 'Sulfadoxine', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000293', 'descriptor_name': 'Adolescent', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000962', 'descriptor_name': 'Antimalarials', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000962', 'descriptor_name': 'Antimalarials', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D002738', 'descriptor_name': 'Chloroquine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002738', 'descriptor_name': 'Chloroquine', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D002738', 'descriptor_name': 'Chloroquine', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D004311', 'descriptor_name': 'Double-Blind Method', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004338', 'descriptor_name': 'Drug Combinations', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016778', 'descriptor_name': 'Malaria, Falciparum', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015767', 'descriptor_name': 'Mefloquine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015767', 'descriptor_name': 'Mefloquine', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D015767', 'descriptor_name': 'Mefloquine', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011739', 'descriptor_name': 'Pyrimethamine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011739', 'descriptor_name': 'Pyrimethamine', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D013413', 'descriptor_name': 'Sulfadoxine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013413', 'descriptor_name': 'Sulfadoxine', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1080/00034983.1992.11812712', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S135866459', 'display_name': 'Annals of Tropical Medicine and Parasitology', 'issn_l': '0003-4983', 'issn': ['0003-4983', '1364-8594'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320442', 'host_organization_name': 'Maney Publishing', 'host_organization_lineage': ['https://openalex.org/P4310320442'], 'host_organization_lineage_names': ['Maney Publishing'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/1304698', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.85}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 12, 'referenced_works': ['https://openalex.org/W17920466', 'https://openalex.org/W1968963419', 'https://openalex.org/W1976287532', 'https://openalex.org/W2028134250', 'https://openalex.org/W2073023079', 'https://openalex.org/W2086340373', 'https://openalex.org/W2120148445', 'https://openalex.org/W2314731117', 'https://openalex.org/W2409663295', 'https://openalex.org/W2410103394', 'https://openalex.org/W2463443112', 'https://openalex.org/W4254059959'], 'related_works': ['https://openalex.org/W2435000867', 'https://openalex.org/W2410936441', 'https://openalex.org/W22236944', 'https://openalex.org/W2152609980', 'https://openalex.org/W2097339869', 'https://openalex.org/W2084844602', 'https://openalex.org/W2025778096', 'https://openalex.org/W1996426332', 'https://openalex.org/W1982781255', 'https://openalex.org/W1005665245'], 'abstract_inverted_index': {'AbstractFrom': [0], 'July': [1], '1987': [2], 'to': [3, 29], 'June': [4], '1988': [5], 'a': [6, 16], 'randomized,': [7], 'double-blind,': [8], 'comparative': [9], 'placebo-controlled': [10], 'field': [11], 'trial': [12, 165], 'was': [13, 28, 103, 158], 'conducted': [14], 'in': [15, 89, 95, 125, 130, 135, 140, 146, 155, 163, 181], 'group': [17, 143], 'of': [18, 25, 36, 80, 150, 172, 178], 'villages': [19], 'near': [20], 'Ibadan,': [21], 'Nigeria.': [22], 'The': [23], 'aim': [24], 'the': [26, 31, 86, 90, 96, 126, 131, 136, 141, 147, 170, 176], 'study': [27], 'assess': [30], 'suppressive': [32], 'tolerability': [33], 'and': [34, 48, 54, 58, 93, 144, 166], 'efficacy': [35], 'four': [37, 108], 'antimalarials': [38, 162], '(Fansimef®,': [39], 'Lariam®,': [40], 'Fansidar®,': [41], 'chloroquine)': [42], 'given': [43, 51], 'for': [44, 65, 152, 160, 169, 175], '24': [45, 66, 153], 'weeks.': [46, 67], 'Fansimef®': [47, 97, 127, 151], 'Lariam®': [49], 'were': [50, 113], 'with': [52, 100], 'loading': [53], 'maintenance': [55], 'doses,': [56], 'Fansidar®': [57, 137], 'chloroquine': [59, 142], 'as': [60], 'one': [61, 94], 'tablet': [62], 'per': [63, 122], 'week': [64], 'Of': [68], '567': [69], 'enrolled': [70], 'subjects,': [71], '114': [72, 123], '(20%)': [73], 'had': [74], 'parasitaemia': [75, 102], 'on': [76], 'entry.': [77], 'Eight': [78], 'episodes': [79], 'symptomatic': [81], 'falciparum': [82], 'malaria': [83, 180], 'occurred': [84], 'during': [85], 'trial,': [87], 'seven': [88], 'placebo': [91, 148], 'group,': [92, 128, 133, 138], 'group.': [98], 'Compared': [99], 'placebo,': [101], 'effectively': [104], 'suppressed': [105], 'by': [106], 'all': [107], 'drug': [109, 174], 'regimens.Adverse': [110], 'event': [111], 'data': [112], 'not': [114], 'significantly': [115], 'different': [116], 'between': [117], 'groups:': [118], 'six': [119], 'adverse': [120], 'events': [121], 'participants': [124], 'six/113': [129], 'mefloquine': [132], 'five/111': [134], '17/115': [139], 'eight/114': [145], 'group.Safety': [149], 'weeks': [154], 'endemic': [156], 'areas': [157], 'comparable': [159], 'standard': [161], 'this': [164, 173], 'provides': [167], 'support': [168], 'use': [171], 'treatment': [177], 'resistant': [179], 'indigenous': [182], 'African': [183], 'populations.': [184]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W59500062', 'counts_by_year': [{'year': 2021, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 1}], 'updated_date': '2024-12-23T11:57:42.670855', 'created_date': '2016-06-24'}